PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Iloperidone→

Iloperidone PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
133454-47-4
PubChem CID
71360
Molecular formula
C24H27FN2O4
Molecular weight
426.5 g/mol
Drug class
Atypical AntipsychoticAntipsychotic
Mechanism of action
The mechanism of action of iloperidone in schizophrenia and bipolar I disorder is unknown.
Indications / reported uses
  • Schizophrenia

Sources: FDA product labels (openFDA) · FDA product information

Identification source: PubChem record (CID 71360). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Iloperidone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Iloperidone Permitted Daily Exposure (PDE) report (the Iloperidone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Iloperidone Occupational Exposure Limit (OEL) report (the Iloperidone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.